Protocol SummaryBack To Search Instructions
Protocol No.SWOG1400IPrincipal InvestigatorScilla, Katherine
PhasePhase III
Age GroupAdult
TitleA Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients with Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-MAP Sub-Study)
Applicable Disease SitesLung
Drugs InvolvedIpilimumab (MDX-010
StatusOpen (affiliates only)
Treatment TypeTreatment
ContactGreenebaum Comprehensive Cancer Center: Maha Khalil, PhD Phone:410-328-5009
Back to Protocol Listing